MFDS — authorised 22 December 1997
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
🇰🇷 Teveten in South Korea
MFDS authorised Teveten on 22 December 1997
Marketing authorisation
Teveten in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Teveten approved in South Korea?
Yes. MFDS authorised it on 22 December 1997.
Who is the marketing authorisation holder for Teveten in South Korea?
ABBVIE holds the South Korean marketing authorisation.